MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2024 International Congress

    Blood Pressure Profile of PD-MCI and PDD in Parkinson’s Disease Patients at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia

    A. Al Jody, A. Tiksnadi, D. Tunjungsari (Jakarta, Indonesia)

    Objective: This study aims to explore the BP profile in both PD-MCI and PDD Background: Blood pressure (BP) abnormality is often correlated with cognitive impairment. However,…
  • 2024 International Congress

    Prodromal and overt Parkinson’s Disease Epidemiological Study in Brazil (PROBE-PD study): preliminary results

    L. Pedrosa, J. Duarte, G. Pereira, I. Oliveira, S. Titze-de-Almeida, A. Schuh, C. Rieder, G. Valença, P. Brandão, L. Krejcová, B. Santos-Lobato (Belém, Brazil)

    Objective: The Prodromal and overt Parkinson's Disease Epidemiological Study in Brazil (PROBE-PD) aims to estimate the prevalence of PD and other parkinsonisms (drug-induced, vascular, multiple system atrophy,…
  • 2024 International Congress

    The impact of long-term continuous subcutaneous apomorphine infusion on the reduction of remaining medications in levodopa equivalent dosage and on increasing plasma vitamin B12 levels in patients with advanced Parkinson’s disease

    O. Phokaewvarangkul, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To evaluate the plasma levels of vitamin B and homocysteine among 28 advanced PD patients with motor complications before and after continued used of…
  • 2024 International Congress

    Deep Brain Stimulation (DBS) Improves Parkinsonism Caused by Osmotic Demyelination Syndrome (ODS)

    T. Zhang, JC. Wu, HT. Li, Q. Wang, C. Zhang, Y. Yu, W. Yue, SQ. Liang (Tianjin, China)

    Objective: We present a report on a successful case wherein Deep Brain Stimulation (DBS) was employed to alleviate Parkinsonism in a patient suffering from Osmotic…
  • 2024 International Congress

    Expanding the phenotypic spectrum of movement disorders in 22q11.2 deletion syndrome

    N. Reyes, T. Cortez-Grippe, M. Callister, T. Heung, A. Bassett, A. Lang (Toronto, Canada)

    Objective: To formally characterize the evolving spectrum of movement disorders associated with chromosome 22q11.2 deletion syndrome Background: Emerging evidence suggests that a wide range of…
  • 2024 International Congress

    Rare Variant Association Analysis in Kazakhstani Parkinson’s Disease Population: Preliminary Results from GP2 CAT-PD Study

    M. Isayan, N. Zharkinbekova, S. Abdraimova, CH. Shashkin, ZH. Myrzayev, V. Akhmetzhanov, A. Karimova, M. Ganieva, Z. Tavadyan, S. Khachatryan, M. Beridze, S. Sopromadze, I. Khatiashvilli, M. Kekenadze, K. Ceferov, V. Escott-Price, J. Hardy, H. Houlden, R. Kaiyrzhanov (Yerevan, Armenia)

    Objective: To identify rare genetic variants in genes, previously associated with Parkinson’s disease (PD) within a population consisting of individuals with PD and unaffected controls…
  • 2024 International Congress

    Effects of Sample Collection Methods on Skin Sebum Volatilome Composition in Parkinson’s Disease Patients – a Methodological Pilot Study

    V. van Midden, L. Strojnik, M. Mencin, N. Ogrinc, M. Kojović (Ljubljana, Slovenia)

    Objective: ​​​​​​To assess replicability of skin sebum volatile organic compound (VOC) composition 1) within the same subjects; 2) in frozen vs fresh samples, and 3)…
  • 2023 International Congress

    Comparative study of Non-Motor Symptoms and it’s correlation with Quality of Life in Parkinson’s disease and Atypical Parkinsonism

    D. Joshi, A. Kumar, M. Tapadia (varanasi, India)

    Objective: The present study aimed to evaluate and compare the non-motor symptoms and their correlation with quality of life in patients with PD and AP.…
  • 2023 International Congress

    monogenic parkinson´s disease in a chilean cohort

    P. Saffie-Awad, D. Texeira, A. Schumacher-Schuh, T. Leal, M. Inca-Martinez, I. Mata, P. Chana-Cuevas (Santiago, Chile)

    Objective: To describe the minimum prevalence and distribution of monogenic forms of PD in a chilean cohort Background: About 3–5% of Parkinson’s disease (PD) patients…
  • 2023 International Congress

    Movement disorders in osmotic demyelination syndrome: A case series from a tertiary care centre

    A. Panjwani, A. Kumar, A. Ranjan (Patna, India)

    Objective: To assess the radiological and clinical features and characterize the various movement disorders in patients with osmotic demyelination syndrome. Background: Osmotic demyelination syndrome (ODS)…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley